SHOO Q1 2026 Earnings EPS Surprises to the Upside Shares Rise 215 UK Government Acknowledges Absence of Formal Vetting in Prince Andrews Trade Envoy Appointment Late Queens Endorsement Revealed European Stocks Open Higher as Markets Eye Potential Progress in Iran Nuclear Talks XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles EasyJet Losses Deepen Amid Iran WarDriven Fuel Cost Surge and Weakened Demand LB Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher OpenAI Targets Rapid IPO Route Source Reveals as Market Eyes SpaceX Filing